Navigation Links
Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook
Date:2/28/2011

i>STEREOTAXIS, INC.BALANCE SHEETS(Unaudited)December 31,
2010December 31,
2009(Unaudited)AssetsCurrent assets:Cash and cash equivalents

$
35,248,819$
30,546,550Accounts receivable, net of allowance of $367,536 and $322,463 in 2010 and 2009, respectively

13,915,56911,152,648Current portion of long-term receivables

30,80066,800Inventories

5,441,4754,403,675Prepaid expenses and other current assets

4,557,7183,872,535Total current assets

59,194,38150,042,208Property and equipment, net

3,840,6224,790,310Intangible assets

2,578,9861,144,445Long-term receivables

109,266138,441Other assets

38,5375,112Total assets

$
5,761,792$
56,120,516Liabilities and stockholders' equityCurrent liabilities:   Current maturities of long-term debt

$
20,894,091$
3,333,333   Accounts payable

8,796,1823,881,205   Accrued liabilities

6,966,5718,615,287   Deferred contract revenue

6,600,3137,191,492   Warrants

3,541,7984,142,614Total current liabilities

46,798,95537,163,931Long-term debt, less current maturities

8,000,00010,346,655Long-term deferred contract revenue

478,850948,574Other liabilities

8,74120,013Stockholders' equity:Preferred stock, par value $0.001; 10,000,000 shares authorized at 2010 and 2009; none outstanding at 2010

and 2009

--Common stock, par value $0.001; 100,000,000 shares authorized at 2010 and 2009; 54,746,240 and 50,208,171

issued at 2010 and 2009, respectively

54,74650,208   Additional paid-in capital

354,002,770331,249,918   Treasury stock, 40,151 shares at 2010 and 2009

(205,999)(205,999)   Accumulated deficit

(343,376,271)(323,452,784)Total stockholders' equity

10,475,2467,641,343Total liabilities and stockholders' equity

$
5,761,792$
56,120,516STEREOTAXIS, INC.STATEMENTS OF OPERATI
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Stereotaxis Announces Public Offering of Common Stock
4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Installs First System in Taiwan
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ) ... Cava (IVC) Filters - Global Trends, Estimates and Forecasts, ... http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior Vena ... million by 2016. The North America ... value while Europe claims approximately ...
(Date:12/15/2014)... BRIDGEWATER, N.J. , Dec. 15, 2014 ... US (EURONEXT: SAN and NYSE: SNY) are collaborating with ... Cholesterol Counts , an awareness program that will ... and the risks associated with high LDL-C (bad cholesterol). ... .com to take a brief poll and answer ...
(Date:12/15/2014)... --  DaVita HealthCare Partners Inc.  (NYSE: ... most innovative health care communities, today announced that ... Research  (DCR) and  HealthCare Partners Clinical Research , will ... research and data analytics services, specifically in patients ... disease (ESRD), as well as primary care and ...
Breaking Medicine Technology:Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4
... Sept. 22 AstraZeneca today,announced that the United ... additional six-month period of exclusivity to market CASODEX(R),(bicalutamide) ... 1, 2009. AstraZeneca has been working with the ... of CASODEX in a pediatric,setting but will not ...
... a biotech company,focused on developing novel therapeutics for ... commercial and manufacturing expertise to,the Company,s senior management ... clinical trials of ENB-0040 for the treatment of,hypophosphatasia., ... Enobia,s Vice President, Chief,Commercial Officer, and Jayant Aphale, ...
Cached Medicine Technology:AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 2AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 3AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 4Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team 2Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team 3
(Date:12/17/2014)... December 17, 2014 Dr. Myo Nwe is ... Loss Diet of the Future” and co-founder of the Ace ... book, Dr. Nwe takes a broad look at the industry ... up under scientific scrutiny. On film and in television shows, ... mostly toward the social aspects and played for basic laughs, ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 HeartMath® ... authorities on stress, heart rate variability (HRV), heart ... licensing its extensive HRV databases and algorithms to ... opportunities will enable HeartMath’s partners to offer its ... extensive research, as well as its normative HRV ...
(Date:12/17/2014)... December 17, 2014 No matter how ... able to eradicate the head louse parasite—a common childhood ... parents. Each year between six and twelve million individuals ... Miami-based lice removal treatment company comes to the rescue, ... environmentally friendly. With its track record of customer service, ...
(Date:12/17/2014)... MONDAY, Dec. 15, 2014 (HealthDay News) -- As gas ... and deaths, a new study suggests. In times ... many of those riders are inexperienced, the researchers explained. ... in California, which has the highest number of motorcycle ... number of motorcyclist deaths. The analysis revealed a ...
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Poor students get more fruits ... new study finds. But, the opposite is true for ... fruits and vegetables at school may give a healthy boost ... no matter what the family income level, students all ate ... study found. The study was published recently in the ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2
... , WEDNESDAY, Nov. 17 (HealthDay News) -- Diabetics may ... is just a cell phone screen away. Researchers ... phone monitoring system that automatically picks up patients, home ... via radio signals from monitoring equipment outfitted with Blue-tooth ...
... mysterious culprit that threatens headaches, stuffy noses, skin rash ... people worldwide drink wine. The discovery could help winemakers ... and whites with less potential to trigger allergy symptoms, ... Journal of Proteome Research . Giuseppe ...
... WEDNESDAY, Nov. 17 (HealthDay News) -- The U.S. Food and ... that their products are illegal. In warning letters to ... malt beverages is an "unsafe food additive," and the companies ... does not find support for the claim that the addition ...
... not been high on the list of targets for treating ... the development of neurodegenerative diseases than has been realized. ... the pericyte in a surprising new role as a key ... brain tissue from harmful substances. By manipulating pericyte levels, scientists ...
... News) -- Get ready, get set, quit! Thursday marks ... which urges all smokers to lay off the habit for at ... about smoking and a large decrease in smoking rates since the ... local and nationwide events meant to encourage smokers to quit for ...
... 17, 2010) HealthGrades, the nation,s leading independent ... patients a list of those hospitals with the ... receiving a donor organ. HealthGrades annual evaluation of ... clinical quality data, based on patient outcomes, for ...
Cached Medicine News:Health News:Cell Phone 'Telemonitoring' May Help Control Blood Pressure 2Health News:Cell Phone 'Telemonitoring' May Help Control Blood Pressure 3Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 3Health News:The pericyte becomes a player in Alzheimer's, other diseases 2Health News:The pericyte becomes a player in Alzheimer's, other diseases 3Health News:The pericyte becomes a player in Alzheimer's, other diseases 4Health News:Smokers Urged to Join Thursday's Great American Smokeout 2Health News:Nation's top hospital organ transplant centers identified by HealthGrades 2
Compression Bra...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
... Test is a clinical chemistry assay that ... the cobalt binding capacity of albumin in ... the early 1990s, IMA is produced when ... tissue in the heart. During ischemia, the ...
Medicine Products: